Eve Lowenstein, MD, PhD

home / authors / eve-lowenstein-md-phd

Articles

Image IQ: When is a biopsy required?

Image IQ: When is a biopsy required?

Kaivon Sobhani, BS;Eve Lowenstein, MD, PhD
July 6th 2018

In this quiz, Kaivon Sobhani, B.S., and, Eve Lowenstein, M.D., Ph.D., FAAD, address dermatofibrosarcoma protuberans (DFSP), keloids, hypertrophic scars and dermatofibromas.

Rare tumors and fibrotic skin lesions

Rare tumors and fibrotic skin lesions

Kaivon Sobhani, BS;Eve Lowenstein, MD, PhD
July 5th 2018

In this review article, Kaivon Sobhani, B.S., and, Eve Lowenstein, M.D., Ph.D., examine fibrotic skin lesions, including the cutaneous tumor dermatofibrosarcoma protuberan (DFSP).

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: Which of the Following 2023 NP & PA Conferences Has Been Your Favorite?
Published: November 7th 2023 | Updated: April 1st 2025
POLL: Which of the Following 2023 NP & PA Conferences Has Been Your Favorite?
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
Published: March 11th 2025 | Updated: April 1st 2025
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
Apoptosis-Based Skin Cancer Treatment Shows Promise
Published: March 15th 2025 | Updated: April 1st 2025
Apoptosis-Based Skin Cancer Treatment Shows Promise
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health
Published: March 7th 2025 | Updated: April 1st 2025
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
Published: March 8th 2025 | Updated: April 1st 2025
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
© 2025 MJH Life Sciences

All rights reserved.